Document:

EX-10.1

 Exhibit 10.1 

RECRO PHARMA, INC. 

2013 EQUITY INCENTIVE PLAN 

1. Purpose. The Recro Pharma, Inc. 2013 Equity Incentive Plan is intended as an additional incentive to current and prospective
employees, consultants and directors of the Company to enter into or remain in the service or employ of the Company or any Affiliate and to devote themselves to the Company’s success. Under the Plan, the Company may provide such persons with
opportunities to acquire or increase their proprietary interests in the Company through options to purchase the Company’s Common Stock, grants of stock appreciation rights and awards of the Company’s Common Stock. Under the Plan, the
Company may grant (i) ISOs, (ii) Nonqualified Options, (iii) Stock Appreciation Rights and (iv) Stock Awards. 
 2.
Definitions. Capitalized terms not otherwise defined in the Plan shall have the following meanings: 

“Affiliate” means a corporation which is a parent corporation or a subsidiary corporation with respect to the Company
within the meaning of section 424(e) or (f) of the Code. 
 “Board” means the Board of Directors of the
Company. 
 “Cause” for termination of employment or service shall have the meaning ascribed thereto in the
Recipient’s employment or service agreement or, in the absence of such a definition, shall mean: (A) a breach by Recipient of his employment or service agreement with the Company or an Affiliate, which breach continues after written notice
is given to him (B) a breach of Recipient’s duty of loyalty to the Company or an Affiliate, including without limitation any act of dishonesty, embezzlement or fraud with respect to the Company or an Affiliate, (C) the commission by
Recipient of a felony, a crime involving moral turpitude or other act causing material harm to the Company’s or an Affiliate’s standing and reputation, (D) Recipient’s continued failure to perform his duties to the Company or an
Affiliate for a reason other than illness or incapacity (E) unauthorized disclosure of trade secrets or other confidential information belonging to the Company or an Affiliate, or (F) has breached any written noncompetition or
nonsolicitation agreement between the Recipient and the Company. 
 “Code” means the Internal Revenue Code of 1986,
as amended from time to time, or any successor statute or statutes thereto. Reference to any particular section of the Code shall include any successor section. 

“Common Stock” means the Common Stock, par value $0.01, of the Company. 

“Company” means Recro Pharma, Inc., a Pennsylvania corporation. 

 “Disability” means, as determined by the Board, (a) the inability
to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than 12
months or (b) Recipient’s becoming disabled within the meaning of section 22(e)(3) of the Code. 
 “Fair
Market Value” of a share of Common Stock on any day means the value for such day as shall be determined in good faith by the Board on the basis of such considerations as the Board deems appropriate and is consistent with section 409A of the
Code and the regulations issued thereunder. 
 “Grant Date” means the effective date on which an Option is granted
to an Optionee under the Plan. 
 “ISO” means an Option granted under the Plan that is intended to qualify as an
incentive stock option within the meaning of section 422(b) of the Code. 
 “Nonqualified Option” means an Option
granted under the Plan that is not intended to qualify as an ISO. 
 “Option” means an option to purchase Common
Stock granted under the Plan, which may be designated as either an ISO or a Nonqualified Option. 
 “Option
Documents” means written documents in such form as approved from time to time by the Board, which shall be given to Optionees and shall set forth the terms and conditions of Options granted to Optionees under the Plan. 

“Optionee” means an employee, consultant or director to whom an Option is granted under the Plan. 

“Option Price” means the price at which Option Shares may be purchased under the terms of an Option. 

“Option Shares” means the shares of Common Stock that may be purchased by an Optionee upon exercise of an Option.

 “Plan” means the Recro Pharma, Inc. 2013 Equity Incentive Plan. 

“Public Offering” means the initial registration of the Common Stock under section 12(g) of the Securities Exchange
Act of 1934, as amended. 
 “Recipient” means an employee, consultant or director to whom an Option, Stock Award or
Stock Appreciation Right is granted under the Plan. 

  
 2 of 13 

 “SAR Shares” means the shares of Common Stock that may be issued in
connection with the Company’s payment upon the exercise of a Stock Appreciation Right. 
 “Stock Appreciation
Right” means a Recipient’s right to receive from the Company, in SAR Shares, cash or a combination thereof, an amount in excess, if any, of (i) if the Stock Appreciation Right is granted in connection with an Option, the Fair Market
Value of such Option Shares on the date of surrender of such Option Shares over the Option Price of such surrendered Option Shares, or (ii) if the Stock Appreciation Right is granted on a stand-alone basis, the Fair Market Value of the Common
Stock on the date of exercise over the initial basis of the Stock Appreciation Right as determined under the Stock Appreciation Right Agreement provided the initial basis shall be at least the Fair Market Value of the Common Stock on the date of
grant. 
 “Stock Appreciation Right Agreement” means the agreement between the Company and Recipient pursuant to
which a Stock Appreciation Right is granted. 
 “Stock Award” means the award of Common Stock granted to a
Recipient under the Plan. 
 “Stock Award Shares” means shares of Common Stock which are issued pursuant to a Stock
Award under the Plan. 
 3. Administration. Prior to a Public Offering, the Plan shall be administered by the Board. The Board
may delegate authority to one or more subcommittees as it deems appropriate. After an initial Public Offering of the Common Stock, the Plan shall be administered by a committee of Board members, which may consist of “outside directors” as
defined under section 162(m) of the Code, and related Treasury regulations, and “non-employee directors” as defined under Rule 16b-3 under the Securities Exchange Act of 1934. However, the Board may ratify or approve any grants as it deems
appropriate, and the Board shall approve and administer all grants made to non-employee directors. To the extent that a committee or subcommittee administers the Plan, references in the Plan to the “Board” shall be deemed to refer to the
committee or subcommittee. 
 The Board shall from time to time at its discretion grant Options, Stock Appreciation Rights and Stock Awards
pursuant to the terms of the Plan. The Board shall have plenary authority to determine the Recipients to whom and the times at which Options, Stock Appreciation Rights and Stock Awards shall be granted, the number of Option Shares to be covered by
Options, whether cash or SAR Shares shall be paid in connection with the exercise of Stock Appreciation Rights, and the number of Stock Award Shares covered by Stock Awards and the price and other terms and conditions (which need not be identical
for all Recipients) thereof, including a specification with respect to whether an Option is intended to be an ISO, subject, however, to the express provisions of the Plan. In making such determinations the Board may take into account the nature of
the Recipient’s services and responsibilities, the Recipient’s 

  
 3 of 13 

 
present and potential contribution to the Company’s success and such other factors as it may deem relevant. The interpretation and construction by the Board of any provision of the Plan or
of any Option, Stock Appreciation Right or Stock Award granted under it shall be final, binding and conclusive. 
 No member of the Board
shall be personally liable for any action or determination made in good faith with respect to the Plan or any Option, Stock Appreciation Right or Stock Award granted under it. No member of the Board shall be liable for any act or omission of any
other member of the Board or for any act or omission on his own part, including but not limited to the exercise of any power and discretion given to him under the Plan, except those resulting from (i) any breach of such member’s duty of
loyalty to the Company or its stockholders, (ii) acts or omissions not in good faith or involving intentional misconduct or a knowing violation of law, and (iii) any transaction from which the member derived an improper personal benefit.

 In addition to such other rights of indemnification as he may have as a member of the Board, and with respect to the administration of
the Plan and the granting of Options, Stock Appreciation Rights and Stock Awards under it, each member of the Board shall be entitled without further action on his part to indemnification from the Company for all expenses (including the amount of
any judgment and the amount of any approved settlement made with a view to the curtailment of costs of litigation, other than amounts paid to the Company itself) reasonably incurred by him in connection with or arising out of any action, suit or
proceeding with respect to the administration of the Plan or the granting of Options, Stock Appreciation Rights or Stock Awards under it in which he may be involved by reason of his being or having been a member of the Board, whether or not he
continues to be such member of the Board at the time of the incurring of such expenses; provided, however, that such indemnification shall not include any expenses incurred by such member of the Board: (i) in respect of matters as to which he
shall be finally adjudged in such action, suit or proceeding to have been guilty of gross negligence or willful misconduct in the performance of his duties as a member of the Board; or (ii) in respect of any matter in which any settlement is
effected in an amount in excess of the amount approved by the Company on the advice of its legal counsel; and provided further that no right of indemnification under the provisions set forth herein shall be available to or accessible by any such
member of the Board unless within five days after institution of any such action, suit or proceeding he shall have offered the Company in writing the opportunity to handle and defend such action, suit or proceeding at its own expense. The foregoing
right of indemnification shall inure to the benefit of the heirs, executors or administrators of each such member of the Board and shall be in addition to all other rights to which such member of the Board would be entitled to as a matter of law,
contract or otherwise. 
 4. Eligibility. All employees of the Company or its subsidiary Affiliates (who may also be officers
or directors of the Company or its subsidiary Affiliates) shall be eligible to receive Stock Awards, Stock Appreciation Rights and Options hereunder, and such Options may be either ISOs or Nonqualified Options. All non-employee directors of the
Company and all consultants or advisory board members providing services to the Company shall be eligible to receive Nonqualified Options, Stock Appreciation Rights and Stock Awards hereunder. All 

  
 4 of 13 

 
employees of the Company’s parent Affiliates (who may also be officers of the parent Affiliate) shall be eligible to receive grants of Stock Awards.) The Board, in its sole discretion, shall
determine whether an individual qualifies as an employee, consultant or Recipient. A Recipient may receive more than one Option, Stock Appreciation Right or Stock Award. No member of the Board shall vote as a member of the Board with respect to the
grant of any Option, Stock Appreciation Right or Stock Award to himself or herself, except in the case when grants are being made to all similarly situated Board members on the same terms and conditions. In cases in which abstention is
required by the foregoing sentence, the affirmative vote of a majority of the remaining members of the Board (or of the sole remaining member of the Board) shall constitute the action of the Board. 

5. Option Shares, SAR Shares and Stock Award Shares. The aggregate maximum number of Option Shares for which Options may be
granted under the Plan, Stock Award Shares subject to Stock Awards granted under the Plan and SAR Shares subject to Stock Appreciation Rights granted under the Plan is One Million Five Hundred Thousand (1,500,000) shares (the “Reserved
Shares”), which number is subject to adjustment as provided in Section 12. On the 31st of January of each year, beginning in 2015, the number of Reserved Shares may be increased by the
Board, without the necessity of further approval from the Shareholders, by an amount equal to the lower of (a) 500,000 shares or (b) four percent (4%) of the Company’s issued and outstanding capital stock, or such lower amount as
determined by the Board in its sole discretion; provided, however, that in no event shall the total number of Reserved Shares exceed in the aggregate Three Million Five Hundred Thousand (3,500,000) shares. 

Option Shares, SAR Shares and Stock Award Shares shall be issued from authorized and unissued Common Stock or Common Stock held in or
hereafter acquired for the treasury of the Company. If any outstanding Option granted under the Plan expires, lapses or is terminated for any reason, the Option Shares or SAR Shares, if applicable, allocable to the unexercised portion of such Option
or Stock Appreciation Right shall be re-added to the Reserved Shares and may again be the subject of an Option, Stock Appreciation Right or Stock Award granted pursuant to the Plan. Stock Award Shares issued pursuant to a Stock Award that are
subsequently reacquired by the Company pursuant to rights reserved upon the grant of such Stock Award shall be re-added to the Reserved Shares and may again be subject to new Options, SAR Shares or Stock Awards. 

6. Term of Plan. The Plan was adopted by the Board of Directors on October 8, 2013; provided, however, the provisions of
the Plan related to ISOs shall terminate and shall not be effective unless, within twelve months of such date, the Plan is approved by the stockholders of the Company as set forth in section 422(b)(1) of the Code. In the event the Plan is not
adopted by the stockholders of the Company within such twelve-month period, all ISOs granted by the Company pursuant to the Plan shall be converted into Nonqualified Options. No Option may be granted under the Plan after October 8, 2023. 

  
 5 of 13 

 7. Terms and Conditions of Options. Options granted pursuant to the Plan shall be
evidenced by Option Documents in such form as the Board shall from time to time approve, which Option Documents shall specify whether the Option is intended to be an ISO or a Nonqualified Option for federal income tax purposes. An Option shall only
be an ISO to the extent it does not exceed the limitation set forth in subsection 7(a) below, is described as an ISO in the Option Document, and is granted to a person who is an employee of the Company or an Affiliate on the Grant Date. All Option
Documents shall comply with and be subject to the following terms and conditions and with any other terms and conditions (including vesting schedules for the exercisability of Options) the Board shall from time to time provide that are not
inconsistent with the terms of the Plan. 
 (a) Number of Option Shares. Each Option Document shall state the number of Option
Shares to which it pertains. In no event shall the aggregate Fair Market Value of the Option Shares (determined on the Grant Date) with respect to which an ISO is exercisable for the first time by the Optionee during any calendar year (under all
incentive equity plans of the Company or its Affiliates) exceed $100,000. 
 (b) Option Price. Each Option Document shall state
the Option Price at which Option Shares may be purchased, which in no event shall be less than the Fair Market Value of the Common Stock on the Grant Date, provided, however, that if an ISO is granted to an Optionee who then owns, directly or by
attribution under section 424(b) of the Code, shares possessing more than ten percent of the total combined voting power of all classes of stock of the Company or an Affiliate, then the Option Price shall be at least 110% of the Fair Market Value of
the Option Shares on the Grant Date. 
 (c) Medium of Payment. An Option shall be exercised by written notice to the Company
upon such terms and conditions as the Option Document may provide and in accordance with such other procedures for the exercise of Options as the Board may establish from time to time. The method or methods of payment of the Option Price to be paid
upon exercise of an Option shall be determined by the Board and set forth in the Option Document, and may consist of (i) cash, (ii) certified check payable to the order of the Company, (iii) a recourse promissory note in a form
acceptable to the Board, (iv) payment through a broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board, (v) shares of Common Stock previously acquired by the Optionee, as permitted in the discretion of
the Board, (vi) reduction in the number of shares of Common Stock otherwise deliverable upon exercise of the Option with a Fair Market Value equal to the aggregate Option Price at the time of exercise (a so-called “cashless
exercise”), or (vii) such other mode of payment as permitted for the issuance of shares under the Pennsylvania Business Corporation Law, as amended, and approved by the Board, or any combination of the foregoing methods of payment. Payment
of the Option Price by a method other than cash shall be subject to such restrictions and limitations as set forth in the Option Document. 

If payment is made in whole or in part in shares of Common Stock already owned by the Optionee, then the Optionee shall deliver to the Company
certificates registered in the name of such Optionee representing shares of Common Stock legally and beneficially owned by such Optionee, free of all liens, claims and encumbrances of every kind and having a Fair Market

  
 6 of 13 

 
Value on the date of delivery of such notice that is not less than the Option Price of the Option Shares with respect to which such Option is to be exercised, accompanied by stock powers duly
endorsed in blank by the record holder of the shares represented by such certificates. In the event that certificates for shares of the Company’s Common Stock delivered to the Company represent a number of shares in excess of the number of
shares required to make payment for the Option Price of the Option Shares (or the relevant portion thereof) with respect to which such Option is to be exercised by payment in shares of Common Stock, the stock certificate issued to the Optionee shall
represent the Option Shares in respect of which payment is made, and such excess number of shares. Notwithstanding the foregoing, the Board, in its sole discretion, may refuse to accept shares of Common Stock in payment of the Option Price. In that
event, any certificates representing shares of Common Stock which were delivered to the Company shall be returned to the Optionee with notice of the refusal of the Board to accept such shares in payment of the Option Price. The Board may impose such
limitations or prohibitions on the use of shares of the Common Stock to exercise an Option as it deems appropriate, subject to the provisions of the Plan. 

(d) Termination of Options. No Option shall be exercisable after the first to occur of the following: 

(i) Expiration of the Option term specified in the Option Document, which shall not exceed ten years from the date of grant (or, in the case
of an ISO, five years from the date of grant if, on such date the Optionee owns, directly or by attribution under section 424(b) of the Code, shares possessing more than ten percent (10%) of the total combined voting power of all classes of
stock of the Company or an Affiliate). 
 (ii) Expiration of one year from the date the Optionee’s employment with the Company or its
Affiliates terminates by reason of the Optionee’s Disability or death. 
 (iii) Expiration of three months (or such shorter period as
the Board may select) from the date the Optionee’s employment with the Company or its Affiliates terminates, unless such termination was due to Disability, death or termination for Cause as described by subsection (d)(iv), below. 

(iv) Immediately upon the date the Optionee’s employment or service with the Company or its Affiliates terminates, if the Board finds,
after full consideration of the facts presented on behalf of both the Company and the Optionee, that the Optionee has been discharged from employment or service with the Company or an Affiliate for Cause. In the event of a finding that the Optionee
has been discharged for Cause, in addition to immediate termination of the Option, the Optionee shall automatically forfeit all Option Shares for which the Company has not yet delivered the share certificates upon refund of the Option Price. 

(v) The date, if any, set by the Board under terms specified in an Option Document to be an accelerated expiration date in the event of a
“Change in Control” (as defined in subsection 7(f) below), provided an Optionee who holds an Option is given written notice at least 30 days before the date so fixed. 

  
 7 of 13 

 (e) Extension of Time to Exercise. The Board may, if it determines that to do so
would be in the Company’s best interests, provide in a specific case or cases to extend the period of time that a Nonqualified Option may be exercised by Optionee whose employment with the Company and its Affiliates has terminated, provided
that the time to exercise an Option shall in no event be extended beyond the original term of the Option as set forth in subsection 7(d)(i). 

(f) Change of Control. In the event of a Change in Control (as defined below), the Board may take whatever action with respect to
the Options outstanding it deems necessary or desirable, including, without limitation, accelerating the vesting, as well as expiration or termination date in the respective Option Documents to a date no earlier than 30 days after notice of such
acceleration is given to the Optionees. If Options granted pursuant to the Plan are accelerated as provided in this subsection 7(f), such Options shall become immediately exercisable in full. A “Change of Control” shall be deemed to have
occurred upon the earliest to occur of the following events: 
 (i) The consummation of a plan of dissolution or liquidation of the Company;

 (ii) the consummation of the sale or disposition of all or substantially all of the assets of the Company; 

(iii) the consummation of a merger or consolidation of the Company with another corporation where the stockholders of the Company, immediately
prior to the merger or consolidation, will not beneficially own, immediately after the merger or consolidation, shares entitling such stockholders to more than 50% of all votes to which all stockholders of the surviving corporation would be entitled
in the election of directors; or 
 (iv) the date any entity, person or group, (within the meaning of Section 13(d)(3) or
Section 14(d)(2) of the Securities Exchange Act of 1934, as amended), (other than (A) the Company or any of its subsidiaries or any employee benefit plan (or related trust) sponsored or maintained by the Company or any of its subsidiaries
or (B) any person who, on the date the Plan is effective, is the beneficial owner of outstanding securities of the Company), shall have become the beneficial owner of, or shall have obtained voting control over, more than fifty percent
(50%) of the outstanding shares of the Common Stock; 
 (g) Sale or Reorganization. If the Company is merged or
consolidated with another corporation, or if the property or stock of the Company is acquired by another corporation, and if the Options are not accelerated as provided in subsection 7(f) above, the Board shall be authorized to substitute the
Options issued under the Plan with options to acquire stock of the merged, consolidated or acquiring corporation, which substitution of options shall comply with the requirements of sections 424(a) and 409A of the Code. 

  
 8 of 13 

 (h) Transfers. No ISO granted under the Plan may be transferred, except by will or
by the laws of descent and distribution. During the lifetime of the Optionee, such ISO may be exercised only by him. 
 (i) Other
Provisions. The Option Documents shall contain such other provisions including, without limitation, additional restrictions upon the exercise of the Option or additional limitations upon the term of the Option, as the Board shall deem
advisable. 
 (j) Amendment. Subject to the provisions of the Plan, the Board shall have the right to amend Option Documents
issued to Optionee, subject to the Optionee’s consent if such amendment is not favorable to the Optionee, except that the consent of the Optionee shall not be required for any amendment made under subsections 7(e) or 7(f) above. 

8. Exercise. No Option shall be deemed to have been exercised prior to the receipt by the Company of written notice of such
exercise and of payment in full of the Option Price for the Option Shares to be purchased. Each such notice shall specify the number of Option Shares to be purchased and shall satisfy the securities law requirements set forth in this Section 8.

 Each exercise notice shall (unless the Option Shares are covered by a then current registration statement or a Notification under
Regulation A under the Securities Act of 1933 (the “Act”)), contain the Optionee’s acknowledgment in form and substance satisfactory to the Company that (i) such Option Shares are being purchased for investment and not for
distribution or resale (other than a distribution or resale which, in the opinion of counsel satisfactory to the Company, may be made without violating the registration provisions of the Act), (ii) the Optionee has been advised and understands
that (A) the Option Shares have not been registered under the Act and are “restricted securities” within the meaning of Rule 144 under the Act and are subject to restrictions on transfer and (B) the Company is under no obligation
to register the Option Shares under the Act or to take any action which would make available to the Optionee any exemption from such registration, (iii) such Option Shares may not be transferred without compliance with all applicable federal
and state securities laws, and (iv) an appropriate legend referring to the foregoing restrictions on transfer and the Stockholders Agreement and any other restrictions imposed under the Option Documents may be endorsed on the certificates.
Notwithstanding the above, should the Company be advised by counsel that the issuance of Option Shares upon the exercise of an Option should be delayed pending (A) registration under federal or state securities laws or (B) the receipt of
an opinion that an appropriate exemption therefrom is available, (C) the listing or inclusion of the shares on any securities exchange or in an automated quotation system or (D) the consent or approval of any governmental regulatory body
whose consent or approval is necessary in connection with the issuance of such Option Shares, the Company may defer the exercise of any Option granted hereunder until such event in A, B, C or D has occurred. 

  
 9 of 13 

 9. Grant of Stock Appreciation Rights. 

(a) General. The Board shall have authority to grant Stock Appreciation Rights under the Plan. Subject to the satisfaction in
full of any conditions, restrictions or limitations imposed in accordance with the Plan or any Stock Appreciation Right Agreement, a Stock Appreciation Right shall entitle the Recipient to surrender to the Company the Stock Appreciation Right in
exchange for SAR Shares, cash or a combination thereof as herein provided, in the amount described in Section 9(c)(ii) hereof. 
 (b)
Grant. Stock Appreciation Rights may be granted in conjunction with all or part of any Option granted under the Plan (“Tandem SARs”), in which case the exercise of the Stock Appreciation Right shall require the cancellation
of a corresponding portion of the Option, and the exercise of an Option shall result in the cancellation of a corresponding portion of the Stock Appreciation Right. In the case of an Nonqualified Stock Option, Tandem SARs may be granted either at or
after the time of grant of such Option and provided the SAR satisfies conditions under Reg. § 1.422-5(d)(3). In the case of an ISO, Tandem SARs may be granted only at the time of grant of such Option. A Stock Appreciation Right may also be
granted on a stand-alone basis. The grant of a Stock Appreciation Right shall occur as of the date the Board determines. Each Stock Appreciation Right granted under this Plan shall be evidenced by a Stock Appreciation Right Agreement, which shall
embody the terms and conditions of such Stock Appreciation Right and which shall be subject to the terms and conditions set forth in this Plan. 

(c) Terms and Conditions. Stock Appreciation Rights shall be subject to such terms and conditions as shall be determined by the
Board, including the following: 
 (i) Period and Exercise. The term of a Stock Appreciation Right shall be established by the
Board. If granted in conjunction with an Option, such Tandem SAR shall have a term which is the same as the term for the Option and shall be exercisable only at such time or times and to the extent the related Options would be exercisable in
accordance with the provisions of Section 7 of the Plan. A Stock Appreciation Right which is granted on a stand-alone basis shall be for such period and shall be exercisable at such times and to the extent provided in the Stock Appreciation
Right Agreement. Stock Appreciation Rights shall be exercised by the Recipient’s giving written notice of exercise in form satisfactory to the Company specifying the portion of the Stock Appreciation Right to be exercised. 

(ii) Amount. Upon the exercise of a Tandem SAR, a Recipient shall be entitled to receive an amount in cash, SAR Shares or both
as determined by the Board or as otherwise permitted in the Stock Appreciation Right Agreement, equal in value to the excess of the Fair Market Value per share of an Option Share at the exercise date over the Option Price of such Option Shares
multiplied by the number of Option Shares in respect of which the Stock Appreciation Right is exercised. In the case of a Stock Appreciation Right granted on a stand-alone basis, the Recipient shall be entitled to receive an amount in cash, SAR
Shares or both as determined by the Board or as otherwise permitted in the Stock Appreciation Right Agreement, 

  
 10 of 13 

 
equal to the value in excess of the Fair Market Value of the Common Stock on the date of exercise of the Stock Appreciation Right over the initial basis of the Stock Appreciation Right as set
forth in the Stock Appreciation Agreement which shall be at least the Fair Market Value of the Common Stock on the date of grant. 
 (iii)
Non-transferability of Stock Appreciation Rights. Tandem SARs shall be transferable only when and to the extent that the related Option would be transferable under the Plan unless otherwise provided in an Agreement. No other Stock
Appreciation Rights granted hereunder may be other than by will, the laws of descent and distribution, or pursuant to a qualified domestic relations order. 

(iv) Termination. Tandem SARs shall terminate at such time as the related Option would terminate under the Plan, unless
otherwise provided in an Agreement as to a Nonqualified Option. All other Stock Appreciation Rights shall terminate as provided in the Stock Appreciation Right Agreement. No Stock Appreciation Right shall terminate more than ten years from the Grant
Date. 
 (v) Incentive Stock Option. A Stock Appreciation Right granted in tandem with an ISO shall not be exercisable unless
the Fair Market Value of the Common Stock on the date of exercise exceeds the Option Price. In no event shall any amount paid pursuant to the Stock Appreciation Right exceed the difference between the Fair Market Value on the date of exercise and
the Option Price. 
 10. Lock-Up. If so requested by the Company or any representative of the underwriters in connection with
any underwritten offering of securities of the Company under the Act, an Optionee shall not sell or otherwise transfer any shares or other securities of the Company during the 30-day period preceding and the 180-day period following the effective
date of a registration statement of the Company filed under the Act for such underwriting or such shorter period as may be requested by the underwriters and agreed to by the Company (the “Market Standoff Period”). The Company may impose
stop-transfer instructions with respect to securities subject to the foregoing restrictions until the end of such Market Standoff Period. 

11. Grant of Stock Awards. Stock Awards will consist of shares of Common Stock transferred to Recipients, without payment or
other consideration therefor. Stock Awards shall be subject to such terms and conditions as the Board determines appropriate, including without limitation, restrictions on sale or other disposition of such Stock Award Shares, and the rights of the
Company to reacquire such Stock Award Shares upon termination of Recipients employment with the Company within specified periods, whether for Cause or otherwise. 

12. Adjustments on Changes in Common Stock. The aggregate number of shares of Common Stock as to which Options may be granted
hereunder, the number of Option Shares covered by each outstanding Option, the Option Price per Option Share specified in each outstanding Option, the number of SAR Shares subject to Stock Appreciation Rights and the number of Stock Award Shares
subject to Stock Awards granted hereunder shall be appropriately 

  
 11 of 13 

 
adjusted in the event of a stock dividend, stock split or other increase or decrease in the number of issued and outstanding shares of Common Stock resulting from a subdivision or consolidation
of the Common Stock or other capital adjustment (not including the issuance of Common Stock on the conversion of other securities of the Company which are convertible into Common Stock) effected without receipt of consideration by the Company. The
Board shall have the authority to determine the adjustments to be made under this Section and any such determination by the Board shall be final, binding and conclusive, provided that no adjustment shall be made which will cause an ISO to lose its
status as such or will cause any Option or Stock Appreciation Right to lose its status as exempt from Code Section 409A. 
 13.
Amendment of the Plan. The Board may amend the Plan from time to time in such manner as it may deem advisable. Notwithstanding the foregoing, in the event the Plan is adopted by the Company’s stockholders pursuant to
Section 6, any amendment which would change the class of individuals eligible to receive an Option, extend the expiration date of the Plan, or increase the maximum aggregate number of shares of Common Stock available for issuance under the Plan
will only be effective if such action is approved by a majority of the outstanding voting stock of the Company within twelve months before or after such action. 

14. Continued Employment. The grant of an Option, Stock Appreciation Right or a Stock Award pursuant to the Plan shall not be
construed to imply or to constitute evidence of any agreement, express or implied, on the part of the Company or any Affiliate to retain the Recipient in the employ of the Company or an Affiliate, as a member of the Board, as an independent
contractor or in any other capacity, whichever the case may be. 
 15. Withholding of Taxes. Whenever the Company proposes or
is required to issue or transfer Option Shares, SAR Shares or Stock Award Shares, the Company shall have the right to (a) require the recipient or transferee to remit to the Company an amount sufficient to satisfy any federal, state and/or
local withholding tax requirements prior to the delivery or transfer of any certificate or certificates for such Option Shares, SAR Shares or Stock Award Shares or (b) take whatever action it deems necessary to protect its interests, including
the right to deduct the amount required to be withheld from any payment of any kind otherwise due to the Recipient. If and to the extent permitted by the Board, a Recipient may satisfy applicable withholding requirements by the delivery to the
Company of previously held shares of Common Stock or the withholding of Option Shares, SAR Shares or Stock Award Shares otherwise issuable to the Recipient. 

16. General.  
 (a)
Effective Date. This Incentive Equity Plan shall be effective as of the date specified in Section 6. 
 (b) Issuance
of Option Shares. Subject to the provisions of Section 8, the Company shall effect the issuance of Option Shares purchased under an Option as soon as practicable after the exercise thereof, payment of the Option Price thereof and
compliance with 

  
 12 of 13 

 
any requirements for the withholding of income taxes. No Optionee or other person exercising an Option shall have any of the rights of a stockholder of the Company with respect to Option Shares
purchased as a result of such exercise until due exercise and full payment has been made and the requirements of Section 8 have been satisfied. No adjustment shall be made for cash dividends or other rights for which the record date is prior to
the date of such due exercise and full payment. 
 (c) Other Plans. The adoption of the Plan shall not be construed as creating
any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including without limitation the awarding of stock options otherwise than under the Plan. Unless otherwise provided by the Board in an
Option Document or in a written agreement between the Recipient and the Company or an Affiliate except as may otherwise be provided for under a pension or welfare benefit plan subject to ERISA, the amounts deemed paid to a Recipient under the Plan
shall not be taken into account, in any manner, as salary, compensation or bonus in determining the amount of any payment under any pension, retirement, or other employee benefit plan, program or policy of the Company or any Affiliate. 

(d) Governing Law. The validity, construction, interpretation and effect of the Plan and Option Documents, Stock Appreciation
Right Agreements and Stock Awards issued under the Plan shall be governed and construed by and determined in accordance with the laws of the Commonwealth of Pennsylvania, without giving effect to the conflict of laws provisions thereof. 

17. Compliance with 409A and ISO Requirements. 

(a) Exemption from and Compliance with 409A. The Board shall administer, construe, and interpret the Plan, and
exercise its authority and discretion, so that all Options, Stock Appreciation Rights or Stock Awards granted under the Plan satisfy the requirements for an exemption from or comply with Code Section 409A and that Options intended to be ISOs
are eligible for that tax treatment. 
 (b) Contemplated Amendments. It is expressly contemplated that the Board may amend the
Plan, any Option Document, any Stock Appreciation Right Agreement, or terms of any Stock Award in any respect the Board deems necessary or advisable to provide the Recipient with the maximum benefits provided or to be provided under the provisions
of the Code and the regulations promulgated thereunder relating to ISOs or to avoid additional income taxes and other consequences arising from nonqualified deferred compensation that is not exempt from or that does not comply with Code
Section 409A and/or to bring the Plan and/or the Option, Stock Appreciation Right, or Stock Award granted under it into compliance with or qualification for exemption from Code Section 409A or, as to ISOs, eligibility for ISO tax
treatment. 
 (c) No Obligation. Notwithstanding any other provision of the Plan, any Option Document, any Stock
Appreciation Right Agreement, or terms of any Stock Award, the Company, any Affiliate, the Board, or any of their employees or agents, (i) shall have no obligation to take any action to prevent the assessment of any additional income tax,
excise tax or penalty on any Recipient because of Code Section 409A and (ii) shall have no such liability to any Recipient for any such taxes or penalty. 

  
 13 of 13EX-10.2

 Exhibit 10.2 

RECRO PHARMA, INC. 

2013 EQUITY INCENTIVE PLAN 

AWARD AGREEMENT 

FOR 
  

 
 We are pleased
to advise you that Recro Pharma, Inc. (the “Company”) hereby awards to you under the Recro Pharma, Inc. 2013 Equity Incentive Plan (the “Plan”) the right to purchase (an “Option”)
            shares of Common Stock of the Company (“Shares”), subject to your signing this Agreement. The date of award of the Options shall for all purposes be
            , 201     (the “Grant Date”). The Options issued hereunder are “non-qualified options” for tax purposes. 

This award is subject in all respects to the applicable provisions of the Plan, a complete copy of which has been furnished to you and receipt
of which you acknowledge by acceptance of the award. Such provisions are incorporated herein by reference and made a part hereof (including all defined terms). 

All capitalized terms used but not defined herein will have the meanings ascribed to them in the Plan. In addition to the terms, conditions
and restrictions set forth in the Plan, all terms, conditions and restrictions set forth in this Agreement are applicable to the award of Options as evidenced hereby: 

1. Vesting. The Options awarded by this Agreement shall vest ,i.e., become exercisable, in accordance with the
following schedule and conditions: 
 (a)             of the Options shall be
vested on the Grant Date;             of the Options shall vest on             , such that the Options shall be fully vested on
            ; provided, however, that no portion of the Options shall vest unless you continue to serve as             of
the Company on the applicable vesting date. 
 (b) Notwithstanding the foregoing, any unvested Options shall become immediately and fully
vested upon your death, Disability or a Change in Control, provided you are serving as a director the Company immediately prior to the date of such event. 

2. Expiration of Option. Your rights with respect to your Options, whether vested or unvested, shall expire on the
earliest to occur of the following: 
 (a) three months after termination of your service with the Company and/or its affiliates for any
reason other than death, Disability, or Cause; 
 (b) one year after termination of your service with the Company and/or its affiliates due
to death or Disability; 

 (c) the date and time of termination of your service with the Company and/or its affiliates for
Cause; and 
 (d) the tenth anniversary of the Grant Date. 

3. Exercise of Options. 

(a) The exercise price for each Share under your Option is $            (the
“Option Price”). 
 (b) In order to exercise any Option which has vested, you must (i) provide the Company with written notice
of your intention to exercise the Option and the number of Shares you intend to acquire, (ii) execute a counterpart to any shareholders agreement or other agreement as requested by the Company which has been executed by other shareholders of
the Company and is in effect at the time of exercise (collectively, “Shareholders Agreement”), and (iii) deliver a check for the Option Price multiplied by the number of Shares being acquired or such other manner of payment as
approved by the Company. As an alternative to delivering a check you may choose to exercise any vested Option hereunder on a “cashless” basis. Under this method, you do not have to remit the Option Price under the option in cash. Instead,
the Option Price is paid by reducing the number of Shares otherwise issuable to you upon exercise by such number of Shares having a Fair Market Value (determined at the time of exercise) equal to the Option Price. You shall only have rights as a
shareholder of the Company with respect to Shares which have been issued after the Options have vested and been exercised. 

4. Withholding. The Company shall withhold all applicable income and employment taxes on the date of
exercise, cash-out of Options or such other date as required by the Code. If there is insufficient compensation due from the Company to you at the time such withholding is due, the Company shall have the right, prior to delivery of any certificate
or certificates for Shares, to require you to remit to the Company an amount equal to the excess of your share of the income and employment taxes subject to withholding over the amount of compensation then due from the Company to you. 

5. Registration of Shares. The Company may postpone the issuance and delivery of any Shares until the completion or
amendment of any registration or qualification of the shares under any federal or state law, rule or regulation which the Company may determine to be necessary or advisable. In the event that, at the time of issuance of the Shares to you, the Shares
have not been registered or otherwise qualified as may be required under applicable securities laws, you shall, prior to the issuance of the Shares: (i) represent to the Company in form satisfactory to counsel for the Company, that you are
acquiring the Shares for your own account and not with a view to the resale or distribution thereof, and (ii) agree that none of the Shares issued to you pursuant to exercise of the Option provided hereby may be sold, transferred or otherwise
disposed of unless: (a) the Shares to be sold, transferred or otherwise disposed of will be registered or qualified under applicable securities laws at the time of such sale, transfer or other disposition and the Company has received an opinion
of counsel satisfactory to it that such registration or qualification is effective; or (b) the Company shall have received an opinion of counsel or other information and representations, satisfactory to it, to the effect that such registration
or qualification is not required. You shall also consent to execute any market standoff or lock-up agreement as requested by the Company. 

  
 -2- 

 6. No Right of Continued Employment or Service. Nothing contained in the
Plan or this Agreement shall restrict the right of the Company and/or its affiliates to terminate your employment or service. Any termination of your employment or service, regardless of the reason therefor, shall have the consequences provided for
in the Plan and this Agreement with respect to your rights under the Plan. 
 7. Company’s Right of First Refusal
Before any Shares issued under the Options held by you or any transferee (either referred to as the “Holder”) may be sold or otherwise transferred (including transfer by gift or operation of law), the Company shall have a right of first
refusal, to purchase the Shares on the terms and conditions set forth in this Section (the “Right of First Refusal”). 
 (a) The
Holder of the Shares shall deliver to the Company a written notice (the “Notice”) stating: (i) the Holder’s bona fide intention to sell or otherwise transfer such Shares; (ii) the name of each proposed purchaser or
other transferee (“Proposed Transferee”); (iii) the number of Shares to be transferred to each Proposed Transferee; and (iv) the bona fide cash price or other consideration for which the Holder proposes to transfer the Shares
(the “Offered Price”). 
 (b) At any time within thirty (30) days after receipt of the Notice, the Company may, by giving
written notice to the Holder, elect to purchase all, but not less than all, of the Shares proposed to be transferred to any one or more of the Proposed Transferees, at the purchase price determined in accordance with subsection (c) below. 

(c) The purchase price (“Purchase Price”) for the Shares purchased by the Company under this Section shall be the Offered Price. If
the Offered Price includes consideration other than cash, the cash equivalent value of the non-cash consideration shall be determined by the Board of Directors of the Company in good faith. Payment of the Purchase Price shall be made, at the option
of the Company in cash (by check), by cancellation of all or a portion of any outstanding indebtedness of the Holder to the Company or by any combination thereof within 30 days after receipt of the Notice or in the manner and at the times set forth
in the Notice. 
 (d) If all of the Shares proposed in the Notice to be transferred to a given Proposed Transferee are not purchased by the
Company as provided in this Section, then the Holder may sell or otherwise transfer such Shares to that Proposed Transferee at the Offered Price or at a higher price, provided that such sale or other transfer is consummated within 120 days after the
date of the Notice, that any such sale or other transfer is effected in accordance with any applicable securities laws and that the Proposed Transferee agrees in writing that the provisions of this Section shall continue to apply to the Shares in
the hands of such Proposed Transferee. If the Shares described in the Notice are not transferred to the Proposed Transferee within such period, a new Notice shall be given to the Company, and the Company and/or its assignees shall again be offered
the Right of First Refusal before any Shares held by the Holder may be sold or otherwise transferred. 

  
 -3- 

 (e) The Right of First Refusal shall terminate as to any Shares upon the first sale of common
stock of the Company to the general public pursuant to a registration statement filed with and declared effective by the Securities and Exchange Commission under the Securities Act of 1933, as amended. 

(f) To the extent that the provisions of this Section 7 conflict with the terms of any Shareholders Agreement to which the Holder is a
party or by which such Holder is bound, the terms of such Shareholders Agreement shall govern. 
 8. Company’s Repurchase
Right. 
 (a) You understand that following your termination of employment or service with the Company and its affiliates, the
Company shall have the right to purchase from you in accordance with the terms of this Section any and all Shares that you acquire pursuant to an exercise of an Option at a price per Share equal to the Fair Market Value thereof as of the date of
repurchase (the “Repurchase Right”). 
 (b) The Company may elect to purchase the Shares acquired under an Option by delivery of
written notice (the “Purchase Notice”) to you at any time. The Purchase Notice will set forth the number of Shares to be acquired from you, the aggregate consideration to be paid for such Shares and the time and place for the closing of
the transaction. 
 (c) The closing of the repurchase transaction will take place on the date designated by the Company in the Purchase
Notice, which date will not be more than thirty (30) days nor less than ten (10) days after the delivery of such notice. The Company will pay for the Option Shares to be purchased pursuant to the Purchase Notice in a cash payment. At the
closing, you will deliver the certificates representing the Shares to be sold duly endorsed in form for transfer to the Company, and the Company will be entitled to receive customary representations and warranties from you regarding the Shares. 

(d) The Repurchase Right shall terminate as to any Shares upon the first sale of common stock of the Company to the general public pursuant to
a registration statement filed with and declared effective by the Securities and Exchange Commission under the Securities Act of 1933, as amended. 

9. Amendment. Except for limited circumstances provided for at Plan Section 17(b), which permit the company to make
certain unilateral amendments, this Agreement may be amended, in whole or in part and in any manner not inconsistent with the provisions of the Plan, at any time and from time to time, by written agreement between the Company and you. 

10. Notice. Any notice to be given to the Company shall be in writing and either hand delivered or mailed to the office
of the President of the Company. If mailed, it shall be addressed to the Company at 490 Lapp Road, Malvern, PA 19355. Any notice given to you shall be addressed to you at your address as reflected in the personnel records of the Company, or at such
other address as either party hereto may hereafter designate by like notice to the other. Notice shall be deemed to have been duly delivered when hand delivered or, if mailed, on the fifth day after such notice is postmarked. 

  
 -4- 

 The undersigned hereby acknowledges the award of Options on behalf of the Company. 

 

			
	RECRO PHARMA, INC.
		
	By:	 	 
		 	Gerri Henwood, President

 In order to indicate your acceptance of the award of Options granted by this Agreement subject to the
restrictions and upon the terms and conditions set forth above and in the Plan, please execute and immediately return to the Company the enclosed duplicate original of this Agreement. 

 

	
	ACCEPTED AND AGREED,
	Intending to be legally bound:
	
	   

	Holder’s Signature
	
	   

	Date

  
 -5-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}]]